MYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species

S Ray, KR Atkuri, D Deb-Basu, AS Adler, HY Chang… - Cancer research, 2006 - AACR
MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation
and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, …

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update

…, S Dolia, N Shah, S Verma, S Savale, S Ray - Process …, 2023 - Elsevier
The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific …

[HTML][HTML] HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1

ZQ Yao, A Eisen-Vandervelde, S Ray, YS Hahn - Virology, 2003 - Elsevier
Hepatitis C virus (HCV) is efficient in the establishment of persistent infection. We have
previously shown that HCV core protein inhibits T cell proliferation through its interaction with the …

Hepatitis C virus: immunosuppression by complement regulatory pathway

ZQ Yao, S Ray, A Eisen-Vandervelde… - Viral …, 2001 - liebertpub.com
Hepatitis C virus (HCV) infection in humans is almost invariably associated with viral
persistence and chronic hepatitis. HCV-induced chronic hepatitis is a major risk factor for the …

Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection-Findings from a Prospective, Randomized …

…, A Chaturvedi, N Shah, P Patel, R Patel, S Ray - medRxiv, 2021 - medrxiv.org
Background COVID-19 hyper-immune globulin (HIG) solution is a human plasma-derived,
highly-purified, concentrated, virus-inactivated preparation of neutralizing antibodies (NAbs) …

[HTML][HTML] Viral clearance strategy using a three-tier orthogonal technology platform

S Ray, K Tarrach - BioPharm International, 2008 - biopharminternational.com
Removing viral contaminants from animal cell-culture derived biologicals is a major challenge
of downstream purification because it involves laborious and time-consuming techniques …

Biochemical and Functional Characterization of Plasma Derived Human Celestrase 1

S Dolia, S Verma, S Ray - Plasmatology, 2024 - journals.sagepub.com
… of Plasma Derived Human Celestrase 1 - Sheetal Dolia, Sachin Verma, Suma Ray, 2024 …
Suma Ray, PhD 1 … Suma Ray has provided technical input and guidance for this project. …

Quality attributes of plasma derived human fibrinogen (fibrogen-I®)

S Dolia, S Verma, A Pawar, S Ray - Plasmatology, 2021 - journals.sagepub.com
Suma RaySuma Ray, Plasma Operations, Intas Pharmaceuticals Ltd (Plasma Fractionation
unit), … Dr Suma Ray provided continuous technical inputs and mentorship for this project. …

[PDF][PDF] RINT WITH PERMISSION O REPRINT WITH

…, S Dolia, A Pawar, S Ray - BioProcess …, 2021 - eu-assets.contentstack.com
April 2021 19 (4) BioProcess International 31 than classical CP therapy. The resulting drug
product would provide more consistent antibody levels in each lot, and units would be easy …

[HTML][HTML] Characterization of high-purity, double virus inactivated and stable plasma-derived anti-haemophilic clotting factor-VIII/vWF complex

…, A Pawar, S Bardhan, V Patel, S Verma, S Ray - Annals of …, 2019 - aob.amegroups.org
Background: The success in the management of haemophilia in the last two decades has
been predominantly due to the availability of sufficient quantities of safe anti-haemophilic …